108 related articles for article (PubMed ID: 38734952)
1. Cardiovascular Burden of the V142I Transthyretin Variant.
Selvaraj S; Claggett B; Shah SH; Mentz RJ; Khouri MG; Manichaikul AW; Khan SS; Rich SS; Mosley TH; Levitan EB; Arora P; Goyal P; Haring B; Eaton CB; Cheng RK; Wells GL; Manson JE; Fontana M; Solomon SD
JAMA; 2024 Jun; 331(21):1824-1833. PubMed ID: 38734952
[TBL] [Abstract][Full Text] [Related]
2. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.
Parcha V; Malla G; Irvin MR; Armstrong ND; Judd SE; Lange LA; Maurer MS; Levitan EB; Goyal P; Arora G; Arora P
JAMA; 2022 Apr; 327(14):1368-1378. PubMed ID: 35377943
[TBL] [Abstract][Full Text] [Related]
3. Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US.
Selvaraj S; Claggett BL; Quarta CC; Yu B; Inciardi RM; Buxbaum JN; Mosley TH; Shah AM; Dorbala S; Falk RH; Solomon SD
JAMA Cardiol; 2023 Aug; 8(8):784-788. PubMed ID: 37212191
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults.
Coniglio AC; Segar MW; Loungani RS; Savla JJ; Grodin JL; Fox ER; Garg S; de Lemos JA; Berry JD; Drazner MH; Shah S; Hall ME; Shah A; Khan SS; Mentz RJ; Pandey A
JACC Heart Fail; 2022 Feb; 10(2):129-138. PubMed ID: 35115086
[TBL] [Abstract][Full Text] [Related]
5. The amyloidogenic V122I transthyretin variant in elderly black Americans.
Quarta CC; Buxbaum JN; Shah AM; Falk RH; Claggett B; Kitzman DW; Mosley TH; Butler KR; Boerwinkle E; Solomon SD
N Engl J Med; 2015 Jan; 372(1):21-9. PubMed ID: 25551524
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
Ruberg FL; Maurer MS; Judge DP; Zeldenrust S; Skinner M; Kim AY; Falk RH; Cheung KN; Patel AR; Pano A; Packman J; Grogan DR
Am Heart J; 2012 Aug; 164(2):222-228.e1. PubMed ID: 22877808
[TBL] [Abstract][Full Text] [Related]
7. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
Damrauer SM; Chaudhary K; Cho JH; Liang LW; Argulian E; Chan L; Dobbyn A; Guerraty MA; Judy R; Kay J; Kember RL; Levin MG; Saha A; Van Vleck T; Verma SS; Weaver J; Abul-Husn NS; Baras A; Chirinos JA; Drachman B; Kenny EE; Loos RJF; Narula J; Overton J; Reid J; Ritchie M; Sirugo G; Nadkarni G; Rader DJ; Do R
JAMA; 2019 Dec; 322(22):2191-2202. PubMed ID: 31821430
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Disease and Mortality in Black Women Carrying the Amyloidogenic V122I Transthyretin Gene Variant.
Haring B; Hunt RP; Shadyab AH; Eaton C; Kaplan R; Martin LW; Panjrath G; Kuller LH; Assimes T; Kooperberg C; Wassertheil-Smoller S
JACC Heart Fail; 2023 Sep; 11(9):1189-1199. PubMed ID: 36930136
[TBL] [Abstract][Full Text] [Related]
9. Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men.
Jacobson D; Tagoe C; Schwartzbard A; Shah A; Koziol J; Buxbaum J
Am J Cardiol; 2011 Aug; 108(3):440-4. PubMed ID: 21600538
[TBL] [Abstract][Full Text] [Related]
10. Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population.
Greve AM; Christoffersen M; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
JAMA Cardiol; 2021 Mar; 6(3):258-266. PubMed ID: 33237279
[TBL] [Abstract][Full Text] [Related]
11. Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women.
Franceschini N; Kopp JB; Barac A; Martin LW; Li Y; Qian H; Reiner AP; Pollak M; Wallace RB; Rosamond WD; Winkler CA
JAMA Cardiol; 2018 Aug; 3(8):712-720. PubMed ID: 29971324
[TBL] [Abstract][Full Text] [Related]
12. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
Ruberg FL; Maurer MS
JAMA; 2024 Mar; 331(9):778-791. PubMed ID: 38441582
[TBL] [Abstract][Full Text] [Related]
14. Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.
Pandey A; Omar W; Ayers C; LaMonte M; Klein L; Allen NB; Kuller LH; Greenland P; Eaton CB; Gottdiener JS; Lloyd-Jones DM; Berry JD
Circulation; 2018 Apr; 137(17):1814-1823. PubMed ID: 29352072
[TBL] [Abstract][Full Text] [Related]
15. Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
Razvi Y; Ioannou A; Patel RK; Chacko L; Karia N; Riefolo M; Porcari A; Rauf MU; Starr N; Ganesananthan S; Blakeney I; Kaza N; Filisetti S; Bolhuis RE; Rowczenio D; Gilbertson J; Hutt D; Mahmood S; Lachmann HJ; Wechalekar AD; Kotecha T; Knight DS; Coghlan JG; Petrie A; Whelan CJ; Venneri L; Martinez-Naharro A; Hawkins P; Fontana M; Gillmore JD
Eur J Heart Fail; 2024 Feb; 26(2):383-393. PubMed ID: 37953725
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.
Buxbaum JN; Ruberg FL
Genet Med; 2017 Jul; 19(7):733-742. PubMed ID: 28102864
[TBL] [Abstract][Full Text] [Related]
17. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC
JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837
[TBL] [Abstract][Full Text] [Related]
18. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
Myhre PL; Vaduganathan M; Claggett BL; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
JAMA Cardiol; 2018 Oct; 3(10):1000-1005. PubMed ID: 30140899
[TBL] [Abstract][Full Text] [Related]
19. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population.
Kozlitina J; Garg S; Drazner MH; Matulevicius SA; Ayers C; Overton J; Reid J; Baras A; Rao K; Pandey A; Berry J; de Lemos JA; Grodin JL
J Card Fail; 2022 Mar; 28(3):403-414. PubMed ID: 34634447
[TBL] [Abstract][Full Text] [Related]
20. Pooled cohort equations heart failure risk score predicts cardiovascular disease and all-cause mortality in a nationally representative sample of US adults.
Razavi AC; Potts KS; Kelly TN; He J; Fernandez C; Krousel-Wood M; Anderson AH; Bundy J; Whelton SP; Blumenthal RS; Lloyd-Jones D; Bazzano LA
BMC Cardiovasc Disord; 2020 Apr; 20(1):202. PubMed ID: 32334524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
